Mumbai’s private hospitals—and many across India—have quietly perfected a harrowing business model: convert medical care into a maze of inflated invoices, opaque charges, and coercive payment practices that prey on patients when they are most vulnerable. This is not occasional malpractice; it is a systemic problem enabled by weak oversight, fragmented billing practices, and the power imbalance between frightened families and cash-hungry corporate wards.

Kapadia Hospital charged Rs. 10,000 for an out-patient procedure in which an injection had to be administered; the MRP of the medicine was less than Rs. 150. The entire procedure took less than 10 mins. The administering doctor (name withheld) gave the injection on April 1 for a frozen shoulder. It was only when the query was raised, was the name of the drug provided on the prescription. The patient’s name is being withheld for the safety of the patient. The hospital is located in Goregaon West, Mumbai, Maharashtra, India.

Multiple user reviews on platforms like Justdial indicate that Kapadia Multispeciality Hospital in Mumbai has received complaints regarding overcharging and inflated billing. Patients describe being charged excessive amounts for services, particularly mentioning high room charges and deposits. 

A patient review from a year ago on Justdial reported a “Worst experience” with the hospital, citing they were charged an extra deposit and had difficulties receiving a refund upon discharge. In another review from eight years ago, a patient also called out the hospital’s “hefty charges” and high bed charges. 

General scenario of Mumbai hospitals

The playbook is familiar. Estimates and “packages” are issued with vague language and catch-all clauses. Consumables are billed at multiples of printed MRP. Procedure codes are unbundled into dozens of line items—each with its own markup—so a single intervention multiplies into a staggering total. Items listed as “disposables,” “equipment charges,” or “monitoring fees” hide actual unit costs. Families routinely discover, at discharge, a final bill wildly different from the initial estimate. By then, the hospital leverages urgency: settle now, or remain detained in a bed until the account is cleared.

Insurance adds another layer of complexity. Hospitals and third-party administrators play a cat-and-mouse game with cashless approvals, partial pre-auths, and retrospective downgrades. Patients find their claims denied or reduced because services were coded differently at discharge. The result: out-of-pocket payments that bankrupt households, even as insurers refuse liability on technicalities.

The human cost cannot be overstated. Patients arrive seeking healing and leave burdened with debt, selling assets or foregoing follow-up care. Public trust in healthcare erodes. Small businesses and middle-income families, who assumed insurance would protect them, are learning the opposite.

Fixing this requires decisive policy and operational change. Hospitals must be mandated to provide real, itemized pre-admission estimates with MRP references for all packaged items. Every packaged consumable must be scanned and logged at bedside with a QR code linking to its invoice—transparency that prevents phantom charges. Discharge cannot be contingent on full payment; instead, interim care should allow for immediate transfer of disputes to a regulator or insurer without penalizing the patient. Insurance protocols must clamp down on retrospective reclassification of approved services and enforce penalties where denials are arbitrary.

Regulators should perform random audits of hospital bills and publish summary findings. A binding, time-bound grievance mechanism—an independent healthcare ombudsman with powers to order refunds plus interest—would deter serial offenders. Price caps on markups for common consumables and a legal requirement to display standard MRP and kit contents would further reduce opportunism.

Ethics, not just economics, should govern care. Hospitals that choose to put balance sheets before patients undermine the very purpose of medicine. Mumbai and India can preserve the private sector’s strengths—investment, innovation, capacity—without permitting exploitative billing. Transparency, enforceable patient rights, and rigorous oversight will ensure healthcare returns to its rightful role: a service rooted in care, not a ledger designed to extract.